Anhui Wanbang Pharmaceutical Stock Tumbles Amid Sector Sell‑Off and Regulatory Scrutiny
Market‑wide turbulence hits Anhui Wanbang Pharmaceutical, with a sharp share dip amid false drug‑deal rumors and a broader “innovation‑drug” sell‑off. Discover the key factors affecting investor confidence and the company’s path to regain stability.
4 minutes to read